Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

February 28, 2017

Conditions
Breast Cancer
Interventions
DRUG

nitrous oxide anesthesia

General anesthesia will be maintained by 40% oxygen (FiO2 0.4) with Nitrous Oxide and volatile anesthetic sevoflurane through laryngeal mask airway (LMA Supreme Size 3/4) or endotracheal tube (Size 7.0-7.5). All patients will receive standard anesthetic care and monitoring

DRUG

air anesthesia

General anesthesia will be maintained by 40% oxygen (FiO2 0.4) with air and volatile anesthetic sevoflurane through laryngeal mask airway (LMA Supreme Size 3/4) or endotracheal tube (Size 7.0-7.5). All patients will receive standard anesthetic care and monitoring

DEVICE

laryngeal mask airway (LMA Supreme Size 3/4

DRUG

sevoflurane

Trial Locations (1)

400012

Tata Memorial Hospital, Mumbai

All Listed Sponsors
lead

Tata Memorial Hospital

OTHER_GOV

NCT02736604 - Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries | Biotech Hunter | Biotech Hunter